Acorda Therapeutics, Inc.

📍 Pearl River, United States🗓 Founded 1995👥 288 employees💰 Last funded 2021
Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. We achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment Acorda has been voted one of the best companies to work for in New York for the past five years in a row, as a result of our dynamic environment, strong corporate culture, significant emphasis on research and development, and a robust product pipeline. We are positioned to be an industry leader, poised for exceptional growth. See our community guidelines: http://acor.bio/acordasocial
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1995
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Acorda Therapeutics, Inc.?
Acorda Therapeutics, Inc. has 1 investors on record on gritt.io.
When did Acorda Therapeutics, Inc. last raise funding?
The most recent investment in Acorda Therapeutics, Inc. recorded on gritt.io was in 2021.
When was Acorda Therapeutics, Inc. founded?
Acorda Therapeutics, Inc. was founded in 1995.
What industry is Acorda Therapeutics, Inc. in?
Acorda Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Acorda Therapeutics, Inc. based?
Acorda Therapeutics, Inc. is headquartered in Pearl River, United States.